Cite
HARVARD Citation
Wang, H. et al. (n.d.). Benefit-risk profile of longer-than-1-year dual antiplatelet therapy in TWLIGHT-like patients with high risk of ischemic or bleeding events after drug-eluting stents implantation. European heart journal. p. . [Online].